these findings suggest that because of this cell-selective synergism between no donors and prostacyclin analogs , the concomitant use of molsidomine and iloprost for the treatment of ischemic heart and peripheral vascular disease should be attempted .
C0033567
prostacyclin
C0085096
peripheral vascular disease